15 / 24
(months)
0
6
12
18
24
0
10
20
30
40
50
60
70
80
90
100
O
N
Number of patients at risk :
Treatment arm
106123
6
0
0
168246
63
12
1
Placebo
Pazopanib
Wald test stratified : p<0.0001
Percent
RESULTS: Primary end-point
Progression Free Survival
Placebo
Pazopanib
Median
(months)
1.5
4.6
Hazard ratio
95% CI
1
0.31
(0.24,0.40)
P-value
< 0.0001
(%)
Time